Performance analysis of Jasper Therapeutics (JSPR)
Annual Return
Over the past 3 years, JSPR has had an average annual return of -67.79%, underperforming the benchmark SPY, which returned +22.77% annual.
Since Sep 24, 2021, JSPR has had an average annual return of -69.87%, underperforming the benchmark SPY, which returned +13.63% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -70.25% | -91.44% | +170.88% | +63.64% | -93.86% | -48.08% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -19.01% | -7.14% | -36.26% | +6.90% | -11.29% | -34.55% | -70.25% | ||||||
| 2025 | -71.64% | -2.24% | -27.55% | +27.82% | +0.28% | +0.82% | -47.68% | -3.65% | -15.14% | -3.82% | -19.21% | -0.82% | -91.44% |
| 2024 | +49.23% | +80.36% | +38.22% | -18.69% | +8.74% | -12.58% | -18.52% | +17.91% | -13.73% | +12.62% | +7.71% | -6.30% | +170.88% |
| 2023 | +252.35% | +13.52% | -6.19% | -26.48% | +16.48% | -11.61% | +10.26% | -18.62% | -43.05% | -5.62% | -6.86% | +28.26% | +63.64% |
| 2022 | -39.75% | -20.72% | -5.32% | -14.10% | +3.97% | -39.15% | -2.04% | +0.56% | -58.47% | -7.47% | -14.08% | -23.13% | -93.86% |
| 2021 | -32.14% | -11.02% | -10.19% | -4.26% | -48.08% |
Drawdown analysis of Jasper Therapeutics (JSPR)
The maximum drawdown for the JSPR was -99.68%, occurring on Jun 1, 2026. This drawdown has not yet recovered.
The current JSPR drawdown is -99.67%.
Since Sep 24, 2021 JSPR has experienced the following drawdowns:
- 50% or more: 2 times
- 40% or more: 2 times
- 30% or more: 2 times
- 20% or more: 2 times
- 10% or more: 2 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.68% | Oct 15, 2021 | 1159 | Jun 1, 2026 | Ongoing | Ongoing | Ongoing |
| -52.31% | Sep 24, 2021 | 12 | Oct 12, 2021 | 3 | Oct 15, 2021 | 15 |